Skip to main content
. 2024 Nov 1;16(1):e2024075. doi: 10.4084/MJHID.2024.075

Table 2.

Results for serum ferritin, fecal calprotectin, and Hb at baseline and after 30 and 90 days of treatment.

Baseline After 30 days After 90 days
N Mean (SD) Median (IQR) N Mean (SD) Median (IQR) N Mean (SD) Median (IQR) p-value (0 vs 90)
IPC Serum ferritin (μg/L) 26 7.8 (4.6) 6.7 (4.4–10.4) 25 12.7 (8.5) 11.3 (5.0–16.6) 19 18.6 (13.0) 15.9 (10.4–23.0) 0.002#
Calprotectin (μg/g) 26 256.8 (515.5) 61.6 (16.1–213.3) 24 161.7 (190.9) 114.4 (29.6–227.7) 16 70.6 (60.9) 47.3 (22.1–107.3) 0.290#
Hb (g/dL) 28 10.3 (2.4) 10.7 (8.1–12.6) 25 10.8 (2.2) 11.5 (8.8–12.7) 19 12.1 (1.4) 12.1 (10.9–13.2) 0.002*
SI Serum ferritin (μg/L) 26 6.9 (3.5) 6.6 (4.0–8.8) 24 11.7 (8.5) 9.7 (5.8–13.1) 22 16.5 (11.3) 12.1 (8.5–25.4) 0.001#
Calprotectin (μg/g) 27 139.4 (160.4) 108.5 (34.2–171.8) 26 182.5 (257.4) 85.3 (26.7–253.2) 22 120.9 (162.6) 49.3 (19.8–123.6) 0.964#
Hb (g/dL) 27 11.1 (1.4) 10.9 (10.2–11.9) 25 11.5 (1.5) 11.6 (10.7–12.4) 22 12.1 (1.8) 12.1 (11.5–12.6) 0.003*

IPC: iron polymaltose complex, SI: sucrosomial iron, SD: standard deviation, IQR: interquartile range

*

paired sample t-test

#

Sign-rank test